China GI Health Supplements Reach CN¥ 3.88B in 2025

Executive Summary

China's online GI health dietary supplements market reached CN¥ 3.88 billion in January-September 2025, accelerating +14.5% YoY as consumer spending patterns shift from reactive treatment toward proactive digestive health management. The broader dietary supplements market exceeded CN¥ 87 billion in the same period, growing nearly +19% YoY across Tmall (天猫), JD.com (京东), and Douyin (抖音). This analysis examines how a "treatment plus wellness" dual-track dynamic is reshaping market fundamentals, seasonal purchasing patterns, and the competitive landscape for GI health brands.

A Market in Structural Recovery

The GI health online market demonstrates a compelling growth trajectory characterized by a "treatment plus wellness" dual-track pattern. From January to September 2025, GI health dietary supplements and functional foods reached CN¥ 3.88 billion in online sales, growing +14.5% YoY. This acceleration validates the structural transition from reactive symptom management to proactive health maintenance, as consumers increasingly incorporate GI supplements into daily wellness routines.

Within the broader dietary supplements landscape, GI health represents a modest but steadily recovering segment at approximately 5% of total market value. Sleep management emerged as the standout growth story at +87.4% YoY, while GI health's moderate recovery signals a market rebuilding on sustainable demand fundamentals. The segment's average price point of approximately CN¥ 134 indicates significant room for premiumization as consumers trade up from basic probiotic products to specialized formulations.

Key factors supporting this structural recovery include:

• An aging population with increasing chronic digestive disease prevalence
• Rising health consciousness driving preventive supplementation behavior
• Content-driven commerce models on Douyin effectively educating consumers on product benefits
• GI pharmaceutical market growth (+30% YoY) confirming an expanding patient population

Sleep management leads growth at +87.4% YoY; GI health recovers modestly

Monthly Sales Trajectory: Promotional Events and Seasonal Demand

The monthly sales trajectory reveals a market with clear seasonal dynamics and an underlying structural growth trend. May 2025 peaked at CN¥ 806 million, accounting for nearly 21% of the year-to-date total during the 618 Festival pre-sale period when consumers stockpile health products at promotional prices.

GI health supplement sales accelerate in H1 2025, peaking at CN¥ 806M in May

Pharmaceutical Market Validates Expanding Patient Population

The GI pharmaceutical market provides complementary validation for the supplement sector's growth. Pharmaceutical sales achieved +30% growth, confirming an expanding GI-distressed patient population that feeds downstream demand for preventive supplements.

GI pharmaceutical sales and volume show parallel upward trajectories in 2025

Key Takeaways

• China's GI health supplements market reached CN¥ 3.88 billion in Jan-Sep 2025, growing +14.5% YoY
• May 2025 peaked at CN¥ 806 million during the 618 Festival pre-sale period, accounting for 21% of year-to-date sales
• Broad-based monthly improvements confirm structural growth rather than event-driven demand alone
• GI pharmaceutical market growth of +30% YoY validates an expanding patient population feeding supplement demand
• The segment's CN¥ 134 average price point signals significant premiumization opportunity compared to higher-priced segments

About the Data

This analysis draws on Moojing Market Intelligence data covering January 2024 through September 2025. Moojing tracks 400,000+ brands across 30+ e-commerce platforms, representing 58-65% of China's online retail GMV. For full methodology and additional insights, see the complete GI Health Dietary Supplements & Probiotics whitepaper.